↓ Skip to main content

Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma

Overview of attention for article published in Annals of Hematology, August 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

policy
3 policy sources
twitter
1 X user
patent
2 patents

Citations

dimensions_citation
89 Dimensions

Readers on

mendeley
113 Mendeley
Title
Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma
Published in
Annals of Hematology, August 2013
DOI 10.1007/s00277-013-1879-x
Pubmed ID
Authors

Jeffrey L. Vacirca, Peter. I. Acs, Imad A. Tabbara, Peter. J. Rosen, Peter Lee, Eric Lynam

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Ecuador 1 <1%
Unknown 110 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 24 21%
Other 16 14%
Student > Ph. D. Student 9 8%
Professor > Associate Professor 8 7%
Student > Master 6 5%
Other 21 19%
Unknown 29 26%
Readers by discipline Count As %
Medicine and Dentistry 51 45%
Pharmacology, Toxicology and Pharmaceutical Science 8 7%
Biochemistry, Genetics and Molecular Biology 6 5%
Agricultural and Biological Sciences 6 5%
Computer Science 2 2%
Other 7 6%
Unknown 33 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2024.
All research outputs
#2,492,543
of 23,661,575 outputs
Outputs from Annals of Hematology
#74
of 2,258 outputs
Outputs of similar age
#22,077
of 200,297 outputs
Outputs of similar age from Annals of Hematology
#2
of 28 outputs
Altmetric has tracked 23,661,575 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,258 research outputs from this source. They receive a mean Attention Score of 4.2. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 200,297 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.